comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
novalac aminova nevtralen okus, vrečka v škatli 400 g
prašek - mlečni nadomestki
xphe hello sadne ploščice, okus borovnic, ploščica 40 g 30x
farmacevtska oblika nedoločena - hranila brez fenilalanina
unistrain prrs
laboratorios hipra -
koŽni vbodni (prick) test - control solution (glycerin phosphate buffer)
iris d.o.o. - raztopina za kožni vbodni test - alergijski testi
hemosol b0 raztopina za hemodializo/hemofiltracijo
gambro lundia ab - kalcijev klorid dihidrat; magnezijev klorid heksahidrat; mlečna kislina; natrijev hidrogenkarbonat; natrijev klorid - raztopina za hemodializo/hemofiltracijo - kalcijev klorid dihidrat 5,145 mg / 1 ml magnezijev klorid heksahidrat2,033 mg / 1 ml mlečna kislina5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; magnezijev klorid heksahidrat 2,033 mg / 1 ml mlečna kislina5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; mlečna kislina 5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; natrijev hidrogenkarbonat 3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; natrijev klorid 6,45 mg / 1 ml - zdravila za filtracijo krvi
hemosol b0 raztopina za hemodializo/hemofiltracijo
gambro lundia ab - kalcijev klorid dihidrat; magnezijev klorid heksahidrat; mlečna kislina; natrijev hidrogenkarbonat; natrijev klorid - raztopina za hemodializo/hemofiltracijo - kalcijev klorid dihidrat 5,145 mg / 1 ml magnezijev klorid heksahidrat2,033 mg / 1 ml mlečna kislina5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; magnezijev klorid heksahidrat 2,033 mg / 1 ml mlečna kislina5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; mlečna kislina 5,4 mg / 1 ml natrijev hidrogenkarbonat3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; natrijev hidrogenkarbonat 3,09 mg / 1 ml natrijev klorid6,45 mg / 1 ml; natrijev klorid 6,45 mg / 1 ml - zdravila za filtracijo krvi
biphozyl raztopina za hemodializo/hemofiltracijo
gambro lundia ab - kalijev klorid; magnezijev klorid heksahidrat; natrijev hidrogenfosfat dihidrat; natrijev hidrogenkarbonat; natrijev klorid; kalijev klorid - raztopina za hemodializo/hemofiltracijo - kalijev klorid 0,314 g / 1000 ml magnezijev klorid heksahidrat3,05 g / 1000 ml natrijev hidrogenfosfat dihidrat0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; magnezijev klorid heksahidrat 3,05 g / 1000 ml natrijev hidrogenfosfat dihidrat0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev hidrogenfosfat dihidrat 0,187 g / 1000 ml natrijev hidrogenkarbonat2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev hidrogenkarbonat 2,12 g / 1000 ml natrijev klorid7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; natrijev klorid 7,01 g / 1000 ml kalijev klorid0,314 g / 1000 ml; kalijev klorid 0,314 g / 1000 ml - zdravila za filtracijo krvi
insuman
sanofi-aventis deutschland gmbh - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - diabetes mellitus, kjer je potrebno zdravljenje z insulinom. insuman hitro je tudi primeren za zdravljenje hiperglikemično komi in ketoacidoze, kot tudi za doseganje pred, znotraj - in pooperativne stabilizacije pri bolnikih s sladkorno boleznijo.
removab
neovii biotech gmbh - catumaxomab - ascites; cancer - drugi antineoplastiki - removab je indiciran za intraperitonealno zdravljenje malignih ascitesov pri bolnikih s pozitivnimi karcinomom epcam, pri katerih standardna terapija ni na voljo ali ni več izvedljiva.